No results for ‘’
Kilitch Drugs (India) Ltd
NSE: KILITCH BSE: 524500
₹183.80
(5.41%)
Tue, 26 May 2026, 05:49 pm
Market Cap6.09B
PE Ratio20.62
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1992
- M/s Kilitch Drugs (India) Ltd was incorporated on 12th May.
- The company obtained a certificate for commencement of business dated 26-05-92.
1994
- The company went Public in February for setting up a pharmaceutical formulation plant.
- The company's trading turnover for the year 1994-95 was Rs.550.50 Lacs.
2008
- The Board recommended a final dividend of 10%.
2009
- The Company received a GOLD AWARD for Quality Excellence.
2010
- The Company's Equity Shares were listed at NSE.
2011
2015
- Kilitch Drugs entered a joint venture with a local firm in Ethiopia.
2021
- Kilitch Drugs started production of Cephalosporins Injectables at Ethiopia Plant on 26th July.